Liansu raises $250 million, while WWTT withdraws IPO

The increasingly selective approach by investors also works in favour of Sino Biopharmaceutical which is able to raise $144 million from an upsized placement earlier this week.

Offering further evidence that investors are becoming more selective and cautious amid the continuing volatility in global markets, there were mixed results for three equity deals in Hong Kong this week.

China Liansu managed to sail through after pricing its initial public offering at the bottom of an indicated price range that represented a valuation below the industry average. The plastic pipe company's business, which bankers describe as down-to-earth old fashioned, helped attract investor interest to the IPO,...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition